# Characteristics of Hospitalized Elderly Patients with Severe Pneumonia Due to SARS-CoV-2, Vaccinated Against COVID-19

**Authors:** Jakub Kisiel, Michał Chojnicki, Arleta Kowala-Piaskowska, Katarzyna Wieczorowska-Tobis, Sławomir Tobis, Urszula Religioni, Piotr Merks, Agnieszka Neumann-Podczaska

PMC · DOI: 10.3390/life15060879 · Life · 2025-05-29

## TL;DR

This study examines elderly patients vaccinated against COVID-19 who still died from severe pneumonia caused by SARS-CoV-2.

## Contribution

The study provides a detailed analysis of vaccinated elderly patients who experienced fatal outcomes from severe SARS-CoV-2 pneumonia.

## Key findings

- Only 18 vaccinated elderly patients met the criteria for severe SARS-CoV-2 pneumonia and death.
- Co-existing diseases significantly influenced the prognosis of these patients.
- Descriptive methods highlighted the complex clinical courses of the patients.

## Abstract

The introduction of COVID-19 vaccinations has significantly altered the course of the pandemic by markedly reducing the number of severe infection cases, hospitalizations, and deaths due to COVID-19. Elderly individuals constitute a particularly vulnerable group at risk of severe disease progression, which is often related to decreased immune system effectiveness and comorbidities. Severe infection outcomes in vaccinated individuals, though substantially rarer than in the unimmunized population, can still lead to death due to underlying health conditions. This analysis aims to describe the population of elderly individuals who, despite being vaccinated, died from interstitial pneumonia complicating SARS-CoV-2 infection. Data on the infection course and co-existing diseases were obtained from the database of the Józef Struś Multispecialty City Hospital in Poznań, which was converted into a dedicated facility during the pandemic. The inclusion criteria for the analysis were being over 60 years of age on the day of hospital admission, confirmed pneumonia in radiological examination, COVID-19 infection confirmed by PCR test, and an adverse disease course resulting in death. Patients admitted to the hospital from 1 June 2021 to 31 December 2021 were analyzed. Out of all hospitalizations, only 18 individuals met the inclusion criteria. Given the small number of patients, the authors employed descriptive methods to illustrate the clinical states of the individual patients, presenting SARS-CoV-2 infection in the context of co-existing diseases that significantly affect prognosis. The qualitative analysis employed highlights the complex and multidimensional courses of severely ill COVID-19 patients more emphatically.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096), SARS-CoV-2 (MONDO:0100096), pneumonia (MONDO:0005249)

## Full-text entities

- **Diseases:** Pneumonia (MESH:D011014), death (MESH:D003643), interstitial pneumonia (MESH:D017563), infection (MESH:D007239), COVID-19 (MESH:D000086382)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12194051/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12194051/full.md

---
Source: https://tomesphere.com/paper/PMC12194051